GFAP as a potential biomarker for Alzheimer's disease: a systematic review and meta-analysis

KY Kim, KY Shin, KA Chang - Cells, 2023 - mdpi.com
Blood biomarkers have been considered tools for the diagnosis, prognosis, and monitoring
of Alzheimer's disease (AD). Although amyloid-β peptide (Aβ) and tau are primarily blood …

Markers of microglia in post-mortem brain samples from patients with Alzheimer's disease: a systematic review

KE Hopperton, D Mohammad, MO Trépanier… - Molecular …, 2018 - nature.com
Neuroinflammation is proposed as one of the mechanisms by which Alzheimer's disease
pathology, including amyloid-β plaques, leads to neuronal death and dysfunction. Increases …

Reactive astrogliosis: A friend or foe in the pathogenesis of Alzheimer's disease

A Kumar, IC Fontana, A Nordberg - Journal of neurochemistry, 2023 - Wiley Online Library
Astrocytes are highly efficient homeostatic glial cells playing a crucial role in optimal brain
functioning and homeostasis. Astrocytes respond to changes in brain homoeostasis …

Astrocyte biomarkers in Alzheimer's disease

SF Carter, K Herholz, P Rosa-Neto, L Pellerin… - Trends in molecular …, 2019 - cell.com
Astrocytic contributions to Alzheimer's disease (AD) progression were, until recently, largely
overlooked. Astrocytes are integral to normal brain function and astrocyte reactivity is an …

PET imaging of neuroinflammation in Alzheimer's disease

R Zhou, B Ji, Y Kong, L Qin, W Ren, Y Guan… - Frontiers in …, 2021 - frontiersin.org
Neuroinflammation play an important role in Alzheimer's disease pathogenesis. Advances in
molecular imaging using positron emission tomography have provided insights into the time …

Diverging longitudinal changes in astrocytosis and amyloid PET in autosomal dominant Alzheimer's disease

E Rodriguez-Vieitez, L Saint-Aubert, SF Carter… - Brain, 2016 - academic.oup.com
Abstract See Schott and Fox (doi: 10.1093/brain/awv405) for a scientific commentary on this
article. Alzheimer's disease is a multifactorial dementia disorder characterized by early …

Astrocyte biomarker signatures of amyloid-β and tau pathologies in Alzheimer's disease

JP Ferrari-Souza, PCL Ferreira, B Bellaver… - Molecular …, 2022 - nature.com
Astrocytes can adopt multiple molecular phenotypes in the brain of Alzheimer's disease (AD)
patients. Here, we studied the associations of cerebrospinal fluid (CSF) glial fibrillary acidic …

Correlations of 18F-THK5351 PET with postmortem burden of tau and astrogliosis in Alzheimer disease

R Harada, A Ishiki, H Kai, N Sato… - Journal of nuclear …, 2018 - jnm.snmjournals.org
Clinical PET studies using 18F-THK5351 have demonstrated significant tracer retention in
sites susceptible to tau burden in Alzheimer disease (AD). However, the in vivo PET signal …

Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography

M Schöll, SF Carter, E Westman, E Rodriguez-Vieitez… - Scientific reports, 2015 - nature.com
Studying autosomal dominant Alzheimer's disease (ADAD), caused by gene mutations
yielding nearly complete penetrance and a distinct age of symptom onset, allows …

Relationship Between Reactive Astrocytes, by [18F]SMBT-1 Imaging, with Amyloid-Beta, Tau, Glucose Metabolism, and TSPO in Mouse Models of Alzheimer's …

Y Kong, CA Maschio, X Shi, F **e, C Zuo… - Molecular …, 2024 - Springer
Reactive astrocytes play an important role in the development of Alzheimer's disease (AD).
Here, we aimed to investigate the temporospatial relationships among monoamine oxidase …